SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-040386
Filing Date
2014-05-20
Accepted
2014-05-20 16:05:23
Documents
7
Period of Report
2014-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-12968_28k.htm 8-K 25362
2 EX-99.1 a14-12968_2ex99d1.htm EX-99.1 76222
3 GRAPHIC g129682mmi001.jpg GRAPHIC 47564
4 GRAPHIC g129682mmi002.jpg GRAPHIC 20781
5 GRAPHIC g129682mmi003.jpg GRAPHIC 50624
6 GRAPHIC g129682mmi004.gif GRAPHIC 3503
7 GRAPHIC g129682mmi005.jpg GRAPHIC 2860
  Complete submission text file 0001104659-14-040386.txt   276162
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14857995
SIC: 2834 Pharmaceutical Preparations